TP63 and head and neck squamous cell carcinoma: While these results are compatible with current data indicating that FASN is under the control of multiple oncogenic pathways [17], [60], [62]–[65], they seem to support a model in which p63 sustains FASN expression in the undifferentiated stem cell-like population of human HNSCC.